![]() |
市場調查報告書
商品編碼
1722547
2025 年至 2033 年注射器市場報告(按產品、材料、用途、配銷通路、最終用戶和地區)Syringes Market Report by Product, Material, Usage, Distribution Channel, End User, and Region 2025-2033 |
2024年全球注射器市場規模達211億美元。展望未來,預計2033年市場規模將達到387億美元,2025-2033年期間的成長率(CAGR)為6.99%。政府機構推出的鼓勵個人快速安全接種疫苗的優惠政策是推動市場發展的因素之一。
主要市場促進因素:慢性病盛行率的上升主要推動了市場的發展。此外,由於接受外科手術的人數不斷增加,人們越來越傾向於使用一次性注射器輸送麻醉劑,這也是另一個重要的成長誘導因素。
主要市場趨勢:主要參與者越來越關注高效的消毒手術,同時避免醫療從業者和患者之間的感染,這是擴大市場的新興趨勢之一。除此之外,一次性醫療用品的廣泛普及也對市場產生了進一步的正面影響。
競爭格局:全球市場上一些知名的公司包括 B. Braun Melsungen AG、Baxter International Inc.、Becton Dickinson and Company、Cardinal Health Inc.、Gerresheimer AG、Hindustan Syringes & Medical Devices Ltd.、Nipro Corporation、Pfizer Inc.、Retractable Technologies Inc.、Schott AG、Smiths Inc.、Schlct Group 等。
地理趨勢:由於政府機構推出了許多安全和感染控制舉措,北美在市場上佔據明顯主導地位。此外,在預測期內,先進的製造流程將繼續推動區域市場的發展。
挑戰與機會:阻礙市場發展的關鍵因素之一是針刺傷的風險。然而,為醫療保健專業人員推出全面的培訓計劃以確保正確的使用和處置實踐預計將在未來幾年催化全球市場。
對先進注射器的需求
為提高注射器的安全性和功能性而引入的新技術正在對注射器市場前景產生積極的影響。例如,2024 年 3 月,領先的自毀式和一次性注射器製造商之一印度斯坦注射器和醫療器材公司 (HMD) 推出了自主研發的一次性安全注射器 Dispojekt,以最大限度地減少針刺傷的發生。此外,2024年5月,總部位於德國的醫療保健和醫藥包裝公司Gerresheimer宣布擴建其位於墨西哥克雷塔羅的工廠,以提高即灌裝(RTF)注射器的生產能力,從而滿足北美市場的需求。此外,對家庭醫療保健的偏好轉變以及生物製劑的日益普及也在推動市場的發展。例如,2024 年 3 月,藥物包裝解決方案和輸送系統提供者之一 SCHOTT Pharma 在威爾遜建造了在美國的第一家工廠,用於生產預填充聚合物注射器,以滿足 mRNA 藥物深度冷藏和運輸的需求。該工廠還可以生產用於 GLP-1 療法(例如治療糖尿病或肥胖症的療法)的玻璃預填充注射器。
慢性病盛行率
癌症、糖尿病、心血管疾病等慢性疾病的發生率不斷上升,使得透過注射器定期精確輸送藥物的需求日益增加。歐洲毒品和藥物成癮監測中心(EMCDDA)和歐洲疾病預防和控制中心(ECDC)於 2023 年 11 月發布的報告評估了包括針頭和注射器計劃(NSP)在內的干涉措施在預防個人感染方面的有效性。此外,胰島素注射器在糖尿病日常管理中的廣泛使用也促進了市場的發展。例如,2023 年 11 月,Terumo India 推出了一款胰島素注射器,這是一種為需要定期注射胰島素的患者提供的無菌輸送裝置。它是 Terumo Medical Care Solutions 生命護理解決方案部門的新增部門。與此相符的是,該注射器專門設計有 3 斜面超鋒利針頭和高級矽膠表面,對患者來說更加溫和舒適。其獨特的柱塞保持技術可避免浪費和溢出。此外,美國糖尿病協會估計,美國有數百萬人需要注射胰島素,從而推動了對可靠且方便用戶使用的注射器的需求。
更加重視安全
人們越來越重視改善醫療保健環境中的感染控制,從而刺激先進注射器技術的採用。例如,2024 年 5 月,小分子、生物製劑和疫苗無菌注射劑合約製造商之一 Grand River Aseptic Manufacturing (GRAM) 擴大了其注射器和藥筒產能,為行業不斷提升的生物製劑管道和患者自我給藥的先進藥物輸送系統的成長提供更大的產能。除此之外,政府機構實施嚴格的規定,強制使用安全注射器以防止針刺傷,這也是一個重要的成長誘導因素。例如,2024 年 3 月,美國食品藥物管理局 (FDA) 建議美國醫療保健機構立即停止使用某些未經授權的中國製造的塑膠注射器。這些建議不適用於預充式注射器、玻璃注射器或用於口服或外用的注射器。因此,領先的製造商正在透過推出必需的高品質醫療產品來應對,這將在未來幾年繼續支撐市場。例如,2024年3月,醫療技術公司BD(Becton, Dickinson and Company)提升了其在美國內布拉斯加州和康乃狄克州工廠的注射器國內生產能力,以滿足客戶需求。
The global syringes market size reached USD 21.1 Billion in 2024. Looking forward, the market is expected to reach USD 38.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.99% during 2025-2033. Favorable policies by government bodies for encouraging the fast and safe vaccination of individuals are among the factors fueling the market.
Major Market Drivers: The rising prevalence of chronic diseases is primarily bolstering the market. Moreover, the growing preference for single-use syringes to deliver anesthetics, owing to the increasing number of individuals who are undergoing surgical interventions, is also acting as another significant growth-inducing factor.
Key Market Trends: The inflating focus of key players on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients is one of the emerging trends augmenting the market. Apart from this, the widespread popularity of disposable medical supplies is further positively influencing the market.
Competitive Landscape: Some of the prominent companies in the global market include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Pfizer Inc., Retractable Technologies Inc., Schott AG, Smiths Group plc, Terumo Corporation, and Thomas Scientific LLC, among many others.
Geographical Trends: North America exhibits a clear dominance in the market, owing to the introduction of numerous initiatives by government bodies for safety and infection control. Furthermore, advanced manufacturing processes will continue to fuel the regional market over the forecasted period.
Challenges and Opportunities: One of the key factors hindering the market is the risk associated with needlestick injuries. However, the launch of comprehensive training programs for healthcare professionals to ensure proper usage and disposal practices is expected to catalyze the global market in the coming years.
Demand for Advanced Syringes
The introduction of novel advancements for enhancing the safety and functionality of syringes is positively influencing the syringes market outlook. For example, in March 2024, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of auto-disable and disposable syringes, introduced Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries. Besides this, in May 2024, Gerresheimer, a healthcare and pharmaceutical packaging company based in Germany, announced the expansion of its Queretaro facility in Mexico to increase the production capacities for ready-to-fill (RTF) syringes, thereby catering to the market demand in North America. Additionally, the shifting preference towards home-based healthcare, along with the elevating popularity of biologics, is also propelling the market. For instance, in March 2024, SCHOTT Pharma, one of the pharmaceutical drug containment solutions and delivery systems providers, built its first U.S. facility in Wilson to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications. The site can further produce glass pre-fillable syringes for GLP-1 therapies, such as those that treat diabetes or obesity.
Prevalence of Chronic Diseases
The growing incidences of chronic diseases, including cancer, diabetes, cardiovascular disorders, etc., are escalating the need for regular and precise medication delivery via syringes. The report published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the European Centre for Disease Prevention and Control (ECDC) in November 2023 assessed the effectiveness of interventions, including needle and syringe programs (NSPs), to prevent infections among individuals. Moreover, the widespread usage of insulin syringes for the daily management of diabetes is also bolstering the market. For instance, in November 2023, Terumo India launched an insulin syringe, a sterile delivery device for patients requiring regular insulin injections. It is the addition to the Life Care Solutions division of Terumo Medical Care Solutions. In line with this, specifically designed to have a 3-bevel super sharp needle with a high-grade silicone surface, the syringe is gentle and more comfortable for patients. Its unique feature with plunger retention technology avoids wastage and spillage. Furthermore, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby driving the demand for reliable and user-friendly syringes.
Increasing Focus on Safety
There is a rising emphasis on improving infection control within healthcare settings, thereby stimulating the adoption of advanced syringe technologies. For example, in May 2024, Grand River Aseptic Manufacturing (GRAM), one of the sterile injectable contract manufacturers of small molecules, biologics, and vaccines, expanded its syringe and cartridge capacity to provide greater capacity for the industry's elevating biologics pipeline and the growth in advanced drug delivery systems for patient self-administration. Apart from this, the implementation of stringent regulations by government bodies that mandate the use of safety syringes to prevent needlestick injuries is further acting as a significant growth-inducing factor. For instance, in March 2024, the Food and Drug Administration (FDA) advised healthcare organizations in the U.S. to immediately transition away from using certain unauthorized plastic syringes made in China. The recommendations do not apply to pre-filled syringes, glass syringes, or syringes utilized for oral or topical purposes. Consequently, leading manufacturers are responding by introducing essential high-quality medical products, which will continue to bolster the market in the coming years. For example, in March 2024, BD (Becton, Dickinson and Company), one of the medical technology companies, elevated domestic manufacturing of syringes in Nebraska and Connecticut facilities, U.S., to cater to customer needs.
Among these, general syringes currently exhibit a clear dominance in the market
General syringes, essential tools in medical and healthcare settings, are continually evolving with advancements in technology and design aimed at improving safety, accuracy, and convenience. One of the notable launches is the Medtronic MiniMed 770G Insulin Pump System, which integrates advanced smart technology for precise insulin delivery, catering specifically to diabetes patients. General syringes improve user safety and reduce the risk of accidental injuries, thereby driving the segment's growth.
Currently, glass syringes hold the largest market share
Glass syringes are a crucial component in the medical field, valued for their durability, chemical resistance, and precise delivery capabilities. Unlike plastic syringes, they do not interact with the medications they contain, thereby making them ideal for administering highly reactive or sensitive drugs, such as biologics and certain vaccines. Their use is prominent in the pharmaceutical and biotechnology industries, where maintaining the integrity of the substance is paramount. In January 2024, Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, developed barrier function labels that are generally designed to protect against oxygen ingress for drugs contained in COC syringes.
Disposable syringes hold the largest share in the market
Disposable syringes have become an indispensable tool in modern healthcare due to their convenience, affordability, and ability to reduce the risk of cross-contamination and infection significantly. Designed for single use, these syringes are typically made from plastic and come pre-sterilized, ensuring a high standard of hygiene. Their widespread adoption has been driven by health initiatives aiming to combat the spread of infectious diseases. According to the report by IMARC, the global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
The offline segment, which includes hospitals, clinics, and retail pharmacies, continues to dominate the market due to the immediate availability of products and the trust consumers place in physical purchases, especially for critical healthcare supplies. This traditional distribution method is bolstered by strong relationships between manufacturers and healthcare providers, ensuring a steady supply chain and reliable access to syringes. Conversely, the online segment is experiencing rapid growth, driven by the increasing adoption of e-commerce platforms in the healthcare sector. Online distribution offers significant advantages such as convenience, wider product availability, and competitive pricing, which are particularly appealing to individual consumers and smaller healthcare facilities. Major players in the market, like Becton Dickinson (BD) and Terumo, are leveraging digital platforms to expand their reach and enhance customer engagement.
Syringes play a critical role across various healthcare settings. In hospitals and clinics, they are indispensable for a wide range of procedures, from routine vaccinations and blood draws to administering medications and intravenous therapies. Their reliability and ease of use make them a staple in these high-demand environments. Diagnostic centers heavily rely on syringes for sample collection and diagnostic testing, ensuring accurate and sterile handling of specimens. Specialty centers, such as oncology and diabetes care facilities, utilize them for precise administration of treatments like chemotherapy and insulin, which require meticulous dosing and safety. Other settings, such as outpatient care centers and emergency medical services, depend on syringes for immediate, on-the-go medical interventions, highlighting their versatility and importance in diverse medical scenarios.
North America currently dominates the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the syringes market overview, the rising prevalence of chronic diseases, increased vaccination efforts, and advancements in medical technology are acting as growth-inducing factors in North America. Moreover, in the United States, stringent safety regulations set by the Occupational Safety and Health Administration (OSHA) have led to the widespread adoption of safety-engineered syringes that are designed to minimize needlestick injuries and enhance user safety. Besides this, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby escalating the use of reliable and user-friendly syringes. Furthermore, prominent players like Becton Dickinson (BD) and Novo Nordisk are leading the market with their advanced insulin delivery systems.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
May 2024: Gerresheimer, one of the healthcare and pharmaceutical packaging companies based in Germany, expanded its Queretaro capacity of ready-to-fill (RTF) syringes in Mexico.
March 2024: SCHOTT Pharma built its first U.S. facility to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications.
March 2024: Hindustan Syringes and Medical Devices (HMD), one of the leading providers of auto-disable and disposable syringes, launched Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries.